Middelburg native Bart Sturm wins award for research into breast cancer diagnosis and treatment – We are the City of Middelburg

Middleburger Bart Sturm wins award for research into breast cancer diagnosis and treatment

Cancer. It’s not a pleasant subject to start talking about, but we do it several times a year anyway, because almost everyone faces this disease sooner or later.

Let it sink in for a moment: now. More than 900,000 people are living with cancer. In the Netherlands. Last year, 128,000 new patients were added.

These are the numbers that give you the chills.

The importance of cancer research

But these are also numbers that underscore the importance of cancer research and all the initiatives that exist to support it. Which is why we are excited to report on this again this year. Swim to Fight Cancer MiddelburgOn September 7, from time to time we think about the actions of Westerlicht Walcheren.

However, what we never think about is cancer research itself. As laymen, we can’t say much about this in terms of content, but we know that there are many developments. For example, we regularly see reports in the news about the use of artificial intelligence (AI) in this research. Just search for “Artificial Intelligence + CancerOr “AI + Cancer”.

Bart Storm

And you know what’s really cool? For this very kind of research, a Middelburg native recently won an award at a European conference, Bart Sturm, who Clinical Pathologist Works for Adrz and ZorgSaam.

Because of News item It contains a lot of jargon, so we asked Bart if he wanted to explain it himself. He loved doing so. We quote:

Bart’s research

Breast cancer is the most common form of malignancy in women. One form of this cancer is triple negative cancer, which is insensitive to hormones and the HER2 protein and often has an aggressive course. Chemotherapy is usually the standard treatment for triple negative cancer followed by surgery. In about 65% of these patients, there is little or no (

I conducted scientific research with the aim of predicting which patients would benefit most and which patients would benefit less from chemotherapy, which can be associated with serious side effects.

This research demonstrates that AI, trained on microscopic tumor characteristics, can make reasonably accurate to good predictions based on a tumor tissue biopsy obtained before surgery.

I analyze these microscopic characteristics every day to arrive at what is called PA diagnosis of cancer, among other things. This is often the basis of medical treatment and has inspired and motivated me to do this scientific research. The results of this study will allow for more precise treatment of patients with fewer side effects in the future.

Congress

Bart received an award for this research in European Congress on Digital PathologyThe award confirms the value and importance of his work. The research is the final part of his doctoral thesis at Radboud UMC, which he aims to complete at the end of this year.

We would like to congratulate Bart and wish him much success, as well as the valuable work he and his colleagues do every day for patients in Zealand!